Drug
Estradiol vaginal cream
Estradiol vaginal cream is a pharmaceutical drug with 4 clinical trials. Currently 1 active trials ongoing. Historical success rate of 66.7%.
Total Trials
4
Max Phase
—
Type
DRUG
Molecule
—
Success Metrics
Clinical Success Rate
66.7%
Based on 2 completed trials
Completion Rate
67%(2/3)
Active Trials
1(25%)
Results Posted
50%(1 trials)
Terminated
1(25%)
Phase Distribution
Ph phase_4
1
25%
Ph early_phase_1
1
25%
Ph phase_1
1
25%
Ph phase_3
1
25%
Phase Distribution
2
Early Stage
0
Mid Stage
2
Late Stage
Phase Distribution4 total trials
Early Phase 1First-in-human
1(25.0%)
Phase 1Safety & dosage
1(25.0%)
Phase 3Large-scale testing
1(25.0%)
Phase 4Post-market surveillance
1(25.0%)
Highest Phase Reached
Phase 4Trial Status & Enrollment
Completion Rate
66.7%
2 of 3 finished
Non-Completion Rate
33.3%
1 ended early
Currently Active
1
trials recruiting
Total Trials
4
all time
Status Distribution
Active(1)
Completed(2)
Terminated(1)
Detailed Status
Completed2
Active, not recruiting1
Terminated1
Development Timeline
Analytics
Development Status
Total Trials
4
Active
1
Success Rate
66.7%
Most Advanced
Phase 4
Trials by Phase
Early Phase 11 (25.0%)
Phase 11 (25.0%)
Phase 31 (25.0%)
Phase 41 (25.0%)
Trials by Status
active_not_recruiting125%
terminated125%
completed250%
Recent Activity
1 active trials
Showing 4 of 4
active_not_recruitingphase_4
Preference of Women With Recurrent Urinary Tract Infection for Vaginal Estradiol Tablet vs Cream
NCT05723601
completedphase_3
Study to Evaluate the Equivalence of Estradiol Vaginal Cream to Reference Standard in the Treatment of Vaginal Atrophy
NCT03332303
terminatedearly_phase_1
Vaginal Estradiol Use in Pessary Care
NCT05458375
completedphase_1
Influence of Reproductive Cycle and Menopause on HIV-1 Infection and TFV Gel Activity
NCT01810315
Clinical Trials (4)
Showing 4 of 4 trials
NCT05723601Phase 4
Preference of Women With Recurrent Urinary Tract Infection for Vaginal Estradiol Tablet vs Cream
NCT03332303Phase 3
Study to Evaluate the Equivalence of Estradiol Vaginal Cream to Reference Standard in the Treatment of Vaginal Atrophy
NCT05458375Early Phase 1
Vaginal Estradiol Use in Pessary Care
NCT01810315Phase 1
Influence of Reproductive Cycle and Menopause on HIV-1 Infection and TFV Gel Activity
All 4 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 4